Middle East Pharmaceutical Industries Company (4016)
TDWLMiddle East Pharmaceutical Industries Company
What Changed
Full IR Briefing →Company Overview
Leadership Team
CEO, MD & Director
Chief Marketing Officer
Secretary of the Board of Directors
Chief Operating Officer
Chief Administrative Officer
Compliance Manager
Chief Financial Officer
Chief Commercial Officer
Recent Announcements
No announcements yet.
Data Sources
See Data Freshness Monitor for platform-wide data quality.
Price Chart
Key Metrics
Governance Score
Insufficient data
1/12 dimensions populated
Dividend Safety
0/100
Management Credibility
Low
Accounting Quality
62/100
Caution: M-Score elevated
SouqData provides data for informational purposes only. This does not constitute financial advice, a personal recommendation, or an offer to buy or sell any security. Information may contain errors or be outdated. Always verify data independently and consult a licensed financial adviser before making investment decisions.
Frequently Asked Questions about Middle East Pharmaceutical Industries Company
Where is Middle East Pharmaceutical Industries Company listed?
Middle East Pharmaceutical Industries Company is listed on the Saudi Exchange (Tadawul) (TDWL) in Saudi Arabia under the ticker 4016. SouqData profiles its financials, board and shareholders from public exchange disclosures.
What sector is Middle East Pharmaceutical Industries Company in?
Middle East Pharmaceutical Industries Company (TDWL: 4016) is classified in the Health Care sector. This classification is what SouqData uses for its sector rankings and peer comparisons.
What is the market cap of Middle East Pharmaceutical Industries Company?
Middle East Pharmaceutical Industries Company (TDWL: 4016) has a market capitalisation of about $139M (USD), according to the latest market data held by SouqData. The figure moves daily with the share price.
Middle East Pharmaceutical Industries Company vs sector peers
Health Care · small-cap · 5 peers shown| Company | Market cap (USD) | Dividend yield | Governance | Shariah |
|---|---|---|---|---|
| Middle East Pharmaceutical Industries Company (4016) | $139M | 0.04% | 12(F) | — |
| Dallah Healthcare Co. (4004 · TDWL) | $972M | 0.02% | 24(F) | — |
| Astra Industrial Group (1212 · TDWL) | $868M | 0.02% | 27(F) | — |
| Jamjoom Pharmaceuticals Factory Co. (4015 · TDWL) | $748M | 2.68% | 45(D) | — |
| Dr. Soliman Abdul Kader Fakeeh Hospital Co. (4017 · TDWL) | $561M | 0.01% | 24(F) | — |
| National Medical Care Co. (4005 · TDWL) | $446M | 1.44% | 15(F) | — |
Auto-generated peer set — same GICS sector, comparable market-cap band. Governance score is the unified 8-factor model (independence, board size, CEO/chair separation, attendance, auditor, credentials, committees, pay transparency). Shariah uses AAOIFI Standard No. 21. View all 58 sector peers.
Unlock the full SouqData platform
Get unlimited access to 180+ insight pages, AI copilot, deep research reports, watchlists, portfolio tracking, and the full 210-column screener across 11 MENA exchanges.